Molecular Mechanism of Cross-regulation between DNA Repair and Apoptosis

Huaping Huang

doi:10.54097/s6jfv164

Authors

Huaping Huang

DOI:

https://doi.org/10.54097/s6jfv164

Keywords:

DNA repair, apoptosis, cross-regulation.

Abstract

DNA damage is an inevitable event in cell life activities, and its repair and coping mechanism is the core of maintaining genome stability. When DNA damage occurs, cells activate a complex network of signals that restore genomic integrity through repair mechanisms or initiate programmed apoptosis when the damage is irreversible in order to eliminate potentially harmful cells. The regulation of homeostasis involves several key molecules. As the core molecules regulating these two major processes, tumor suppressor P53 and polyadenosine diphosphoribose polymerase (PARP) play an important role in maintaining genome homeostasis and cell fate determination. In recent years, studies have shown that P53 and PARP form a dynamic balance in DNA damage response through a complex interaction network, and the dysregulation of its regulatory mechanism is closely related to disease progression, especially cancer. This paper aims to systematically elucidate the molecular interaction mechanism between P53 and PARP, explore how they balance cell fate through dynamic synergism or antagonism, and analyze their potential targeting value in tumor therapy. Future studies are needed to further reveal tissue-specific regulatory differences, the effects of epigenetic modifications, and the effects of microenvironmental signals on cross-regulation in order to promote the optimization of individualized treatment programs.

Downloads

Download data is not yet available.

References

[1] Chatterjee N, Walker GC. Mechanisms of DNA damage, repair, and mutagenesis. Environ Mol Mutagen. 2017 Jun;58(5):235-263.

[2] Kang TH. DNA Damage, Repair, and Cancer Metabolism. Int J Mol Sci. 2023 Nov 17;24(22):16430.

[3] Kaina B. DNA damage-triggered apoptosis: critical role of DNA repair, double-strand breaks, cell proliferation and signaling. Biochem Pharmacol. 2003 Oct 15;66(8):1547-54.

[4] Jiang Ting, Zhai Fanfan, Zhong Shanshan, et al. Research progress of DNA damage repair at single molecule level [J]. Nature Journal,2023,45(01):22-32.

[5] Wu Shuheng, Liang Yu, Wu Wei. Advances in high-throughput sequencing of DNA double-strand breaks [J]. Chinese Journal of Cell Biology, 2019,46(08):1488-1496.

[6] Ortega J, Lee GS, Gu L, Yang W, Li GM. Mispair-bound human MutS-MutL complex triggers DNA incisions and activates mismatch repair. Cell Res. 2021 May;31(5):542-553.

[7] Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972 Aug;26(4):239-57. doi: 10.1038/bjc.1972.33. PMID: 4561027; PMCID: PMC2008650.

[8] Mosadegh M, Noori Goodarzi N, Erfani Y. A Comprehensive Insight into Apoptosis: Molecular Mechanisms, Signaling Pathways, and Modulating Therapeutics. Cancer Invest. 2025 Jan;43(1):33-58.

[9] Sun Yan-Ting, Xin Guo-Song, Zhang Lu, et al. Research progress on mitochondrial pathways of apoptosis [J]. Heilongjiang Science and Technology Information,2015(8):30-30.

[10] Hetz C, Zhang K, Kaufman RJ. Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol. 2020 Aug;21(8):421-438.

[11] Green DR. The Death Receptor Pathway of Apoptosis. Cold Spring Harb Perspect Biol. 2022 Feb 1;14(2):a041053.

[12] Menon V, Povirk L. Involvement of p53 in the repair of DNA double strand breaks: multifaceted Roles of p53 in homologous recombination repair (HRR) and non-homologous end joining (NHEJ). Subcell Biochem. 2014;85:321-36.

[13] Song J, Park C, Cabanting FEB, Jun YW. Therapeutic upregulation of DNA repair pathways: strategies and small molecule activators. RSC Med Chem. 2024 Oct 11;15(12):3970–7.

[14] Offer H, Milyavsky M, Erez N, Matas D, Zurer I, Harris CC, Rotter V. Structural and functional involvement of p53 in BER in vitro and in vivo. Oncogene. 2001 Feb 1;20(5):581-9.

[15] Cappello F, Bellafiore M, Palma A, Bucchieri F. Defective apoptosis and tumorigenesis: role of p53 mutation and Fas/FasL system dysregulation. Eur J Histochem. 2002;46(3):199-208.

[16] Follis AV, Llambi F, Merritt P, Chipuk JE, Green DR, Kriwacki RW. Pin1-Induced Proline Isomerization in Cytosolic p53 Mediates BAX Activation and Apoptosis. Mol Cell. 2015 Aug 20;59(4):677-84.

[17] Hikisz P, Kiliańska ZM. PUMA, a critical mediator of cell death--one decade on from its discovery. Cell Mol Biol Lett. 2012 Dec;17(4):646-69.

[18] Dirisina R, Katzman RB, Goretsky T, Managlia E, Mittal N, Williams DB, Qiu W, Yu J, Chandel NS, Zhang L, Barrett TA. p53 and PUMA independently regulate apoptosis of intestinal epithelial cells in patients and mice with colitis. Gastroenterology. 2011 Sep;141(3):1036-45.

[19] Zhou Qiyu, Zhang Nana, Lu Jiangyong, et al. Study on virtual screening, enzyme inhibition activity and metabolic stability of PARP inhibitors [J]. Chinese Chemical Bulletin, 2018,87(07):864-871+844.

[20] Shao Z, Lee BJ, Zhang H, Lin X, Li C, Jiang W, Chirathivat N, Gershik S, Shen MM, Baer R, Zha S. Inactive PARP1 causes embryonic lethality and genome instability in a dominant-negative manner. Proc Natl Acad Sci U S A. 2023 Aug;120(31):e2301972120.

[21] Kutuzov MM, Belousova EA, Kurgina TA, Ukraintsev AA, Vasil'eva IA, Khodyreva SN, Lavrik OI. The contribution of PARP1, PARP2 and poly(ADP-ribosyl)ation to base excision repair in the nucleosomal context. Sci Rep. 2021 Mar 1;11(1):4849.

[22] Jang KH, Jang T, Son E, Choi S, Kim E. Kinase-independent role of nuclear RIPK1 in regulating parthanatos through physical interaction with PARP1 upon oxidative stress. Biochim Biophys Acta Mol Cell Res. 2018 Jan;1865(1):132-141.

[23] Delavallée L, Cabon L, Galán-Malo P, Lorenzo HK, Susin SA. AIF-mediated caspase-independent necroptosis: a new chance for targeted therapeutics. IUBMB Life. 2011 Apr;63(4):221-32.

[24] Dibitetto D, Widmer CA, Rottenberg S. PARPi, BRCA, and gaps: controversies and future research. Trends Cancer. 2024 Sep;10(9):857-869.